Physician profile
Randy Ennen
NPI 1124089222
$1,272.28
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $340 · 2020: $109 · 2021: $414 · 2022: $164 · 2023: $133 · 2024: $112.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $245.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $245.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $506.85 | 2019-2023 | Argos |
| The Cameron-Ehlen Group, INC. | $146.19 | 2021 | |
| Allergan, INC. | $125.00 | 2021 | |
| Horizon Therapeutics Plc | $112.73 | 2022 | |
| Abbvie INC. | $92.39 | 2023-2024 | |
| Carl Zeiss Meditec, INC. | $64.71 | 2019 | |
| Johnson & Johnson Surgical Vision, INC. | $41.92 | 2019-2023 | Tecnis Simplicity |
| Biotissue Holdings INC. | $40.44 | 2021-2022 | |
| Abb Con-Cise Optical Group LLC | $40.28 | 2024 | Spectacle Lenses, Contact Lens |
| Rayner Intraocular Lenses Limited | $34.53 | 2023 | Rayone Aspheric, Rayone Spheric, Rayone Emv |
| Rxsight INC | $18.44 | 2023 | Rxsight Injector Handpiece, Rxsight Light Delivery Device (Ldd), Rxsight Light Adjustable Lens (Rxlal) |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $17.71 | 2020 | |
| Aerie Pharmaceuticals, INC. | $16.00 | 2019 | |
| Iridex Corporation | $15.09 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Randy Ennen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.